Lurie Children’s is actively responding to a cybersecurity matter. For support, please call our dedicated call center at 1.800.543.7362 (M-F: 8 a.m.-6 p.m.; Sat: 8 a.m.-5 p.m.; Sun: Closed). During the hours the Call Center is closed, please call the main operator at 312.227.4000.
Lurie Children’s Division of Allergy and Immunology is at the cutting edge of eczema clinical research. We offer our patients with eczema the newest treatments as well as opportunities to be part of studies in hopes to discover more treatments and a cure.
We are currently recruiting patients in numerous eczema studies. Learn more about our current trials:
Infants with Moderate-Severe Eczema and/or Egg Allergy and Peanut Allergy: Discovering a Significant Genotype This study of children 4 - 11 months with moderate to severe eczema or egg allergy looks to find biomarkers to help tell us whether or not a child will develop a peanut allergy and how severe a peanut allergy might be. Click here for the full study information or call 312.227.5391 for more information.
For more information about our clinical studies, please contact: